LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 389 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,690,811 | +132.4% | 36,810 | +127.1% | 0.00% | 0.0% |
Q4 2023 | $1,157,718 | -25.4% | 16,210 | -37.4% | 0.00% | 0.0% |
Q3 2023 | $1,551,089 | +50113.3% | 25,886 | -38.4% | 0.00% | -50.0% |
Q1 2023 | $3,089 | -77.9% | 41,996 | -80.0% | 0.00% | -75.0% |
Q4 2022 | $14,002 | -99.9% | 209,607 | +26.1% | 0.01% | 0.0% |
Q3 2022 | $14,313,000 | +102.0% | 166,217 | +109.3% | 0.01% | +100.0% |
Q2 2022 | $7,085,000 | -51.9% | 79,410 | -39.4% | 0.00% | -50.0% |
Q1 2022 | $14,737,000 | -27.9% | 131,003 | -0.9% | 0.01% | -20.0% |
Q4 2021 | $20,426,000 | +63.4% | 132,244 | +47.3% | 0.01% | +25.0% |
Q3 2021 | $12,504,000 | -50.3% | 89,749 | -53.2% | 0.01% | -46.7% |
Q2 2021 | $25,166,000 | +16.2% | 191,832 | +35.0% | 0.02% | 0.0% |
Q1 2021 | $21,655,000 | +1610.5% | 142,047 | +1016.2% | 0.02% | +1400.0% |
Q4 2020 | $1,266,000 | -57.2% | 12,726 | -59.0% | 0.00% | -75.0% |
Q3 2020 | $2,955,000 | -61.6% | 31,002 | -55.0% | 0.00% | -63.6% |
Q2 2020 | $7,699,000 | -22.3% | 68,830 | -49.5% | 0.01% | -50.0% |
Q1 2020 | $9,907,000 | +339.5% | 136,233 | +530.2% | 0.02% | +633.3% |
Q4 2019 | $2,254,000 | +20.6% | 21,616 | +15.1% | 0.00% | 0.0% |
Q3 2019 | $1,869,000 | -22.5% | 18,786 | -11.1% | 0.00% | -25.0% |
Q2 2019 | $2,411,000 | +135.9% | 21,125 | +159.9% | 0.00% | +100.0% |
Q1 2019 | $1,022,000 | -98.6% | 8,128 | -98.5% | 0.00% | -98.3% |
Q4 2018 | $74,222,000 | +181.2% | 546,957 | +468.8% | 0.12% | +262.5% |
Q3 2018 | $26,397,000 | +185.7% | 96,166 | +115.6% | 0.03% | +166.7% |
Q2 2018 | $9,240,000 | +1853.5% | 44,600 | +1190.5% | 0.01% | +1100.0% |
Q4 2017 | $473,000 | -49.0% | 3,456 | -54.8% | 0.00% | -50.0% |
Q2 2017 | $928,000 | +305.2% | 7,643 | +239.4% | 0.00% | – |
Q4 2016 | $229,000 | -30.2% | 2,252 | -41.2% | 0.00% | -100.0% |
Q3 2015 | $328,000 | -85.0% | 3,829 | -82.3% | 0.00% | -75.0% |
Q2 2015 | $2,183,000 | -46.1% | 21,632 | -58.8% | 0.00% | -50.0% |
Q1 2015 | $4,053,000 | -50.3% | 52,555 | -65.7% | 0.01% | -52.9% |
Q4 2014 | $8,149,000 | -17.7% | 153,157 | -27.3% | 0.02% | -32.0% |
Q3 2014 | $9,905,000 | +186.0% | 210,783 | +279.2% | 0.02% | +150.0% |
Q2 2014 | $3,463,000 | +37.5% | 55,589 | +48.4% | 0.01% | +42.9% |
Q1 2014 | $2,519,000 | -22.6% | 37,449 | -50.2% | 0.01% | -30.0% |
Q3 2013 | $3,256,000 | +1092.7% | 75,233 | +931.3% | 0.01% | +900.0% |
Q2 2013 | $273,000 | – | 7,295 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |